Format

Send to

Choose Destination
Clin Exp Dermatol. 2017 Apr;42(3):306-308. doi: 10.1111/ced.13038. Epub 2017 Jan 10.

Clearance of recalcitrant warts in a patient with idiopathic immune deficiency following administration of the quadrivalent human papillomavirus vaccine.

Author information

1
Department of Dermatology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
2
Department of Clinical Immunology, Papworth Hospital NHS Foundation Trust, Papworth, UK.
3
Department of Medicine, University of Cambridge, Cambridge, UK.

Abstract

Human papillomavirus (HPV)-induced cutaneous warts are potentially serious and debilitating. In immunosuppressed patients, these warts may be resistant to standard therapies. We report a case of a young patient with a primary immune deficiency whose recalcitrant cutaneous warts regressed completely following administration of a quadrivalent HPV vaccine.

PMID:
28070898
DOI:
10.1111/ced.13038
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center